Sage Therapeutics, Inc. Restricted Cash
Sage Therapeutics, Inc. had Restricted Cash of $700.00 thousand as of 2021-06-30, per its 10-Q filed 2021-11-02.
Discontinued › Balance Sheet › Assets
us-gaap:RestrictedCash · last filed 2023-02-16
- 2021-06-30: Restricted Cash $700.00K.
- 2021-03-31: Restricted Cash $700.00K.
- 2020-12-31: Restricted Cash $700.00K.
| Period end | Restricted Cash |
|---|---|
| 2021-06-30 | $700.00K 10-Q · filed 2021-11-02 |
| 2021-03-31 | $700.00K 10-Q · filed 2021-05-04 |
| 2020-12-31 | $700.00K 10-K · filed 2023-02-16 |